Skip to main content
Top
Published in: Pituitary 2/2011

01-06-2011

Carotid atheromatic plaque is commonly associated with hypopituitary men

Authors: Joo Young Kim, Jae Won Hong, Sang Youl Rhee, Chul Sik Kim, Dae Jung Kim, Eun Jig Lee

Published in: Pituitary | Issue 2/2011

Login to get access

Abstract

Hypopituitarism increases the risks of many cardiovascular conditions and therefore, patients with this disease are more prone to cardiovascular disease. To our knowledge, there have been few studies on carotid artery plaque in male patients with hypopituitarism in assessing cardiovascular risks. The aim of this study was to specifically compare carotid artery plaque while examining other major cardiovascular risk factors between male patients with hypopituitarism and control subjects. Forty male patients aged 30–70 years with hypopituitarism and forty age, sex- matched control subjects were recruited at the Yonsei University Severance Hospital, Seoul, Korea. Carotid intima media thickness (IMT) and atheromatous plaque, anthropometry, lipid profile, and pituitary hormones were assessed. Atheromatous plaque in the carotid arteries was observed more frequently in patients with hypopituitarism than age- and sex-matched control subjects (59.5% vs. 2.5%, P < 0.01) without differences of carotid IMTs. Patients with hypopituitarism also exhibited higher waist circumference, waist to hip ratio, total cholesterol and LDL cholesterol than control subjects. In subgroup analysis in male patients with hypopituitarism including GH deficiency, lower testosterone levels were associated with higher waist circumference (r = 0.446, P = 0.033). In conclusion, hypopituitary males exhibit an increased incidence of carotid artery plaque without differences of carotid IMTs, central obesity and higher total cholesterol level. Lower testosterone levels were associated with central obesity- a strong component of a metabolic syndrome, and unsubstituted testosterone deficiency might be an important cardiovascular risk factor in patients with hypopituitarism.
Literature
3.
go back to reference Fauci AS, Harrison TR (2008) Harrison’s principles of internal medicine, 17th edn. In: Anthony S. Fauci et al (eds) McGraw-Hill Medical, New York Fauci AS, Harrison TR (2008) Harrison’s principles of internal medicine, 17th edn. In: Anthony S. Fauci et al (eds) McGraw-Hill Medical, New York
4.
go back to reference Beshyah SA, Johnston DG (1999) Cardiovascular disease and risk factors in adults with hypopituitarism. Clin Endocrinol (Oxf) 50:1–15CrossRef Beshyah SA, Johnston DG (1999) Cardiovascular disease and risk factors in adults with hypopituitarism. Clin Endocrinol (Oxf) 50:1–15CrossRef
5.
go back to reference Dunne FP, Elliot P, Gammage MD et al (1995) Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism. Clin Endocrinol (Oxf) 43:623–629CrossRef Dunne FP, Elliot P, Gammage MD et al (1995) Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism. Clin Endocrinol (Oxf) 43:623–629CrossRef
6.
go back to reference Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG (2008) Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients. Growth Horm IGF Res 18:318–324CrossRefPubMed Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG (2008) Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients. Growth Horm IGF Res 18:318–324CrossRefPubMed
7.
go back to reference Rosen T, Bengtsson BA (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285–288. doi:0140-6736(90)91812-O[pii]CrossRefPubMed Rosen T, Bengtsson BA (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285–288. doi:0140-6736(90)91812-O[pii]CrossRefPubMed
8.
go back to reference Johnsen SH, Mathiesen EB, Joakimsen O et al (2007) Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the tromsø study. Stroke 38:2873–2880CrossRefPubMed Johnsen SH, Mathiesen EB, Joakimsen O et al (2007) Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the tromsø study. Stroke 38:2873–2880CrossRefPubMed
9.
go back to reference Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE (1997) Common carotid intima-media thickness and risk of stroke and myocardial infarction: the rotterdam study. Circulation 96:1432–1437CrossRefPubMed Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE (1997) Common carotid intima-media thickness and risk of stroke and myocardial infarction: the rotterdam study. Circulation 96:1432–1437CrossRefPubMed
10.
go back to reference Brook RD, Bard RL, Patel S et al (2006) A negative carotid plaque area test is superior to other noninvasive atherosclerosis studies for reducing the likelihood of having underlying significant coronary artery disease. Arterioscler Thromb Vasc Biol 26:656–662CrossRefPubMed Brook RD, Bard RL, Patel S et al (2006) A negative carotid plaque area test is superior to other noninvasive atherosclerosis studies for reducing the likelihood of having underlying significant coronary artery disease. Arterioscler Thromb Vasc Biol 26:656–662CrossRefPubMed
11.
go back to reference Johnsen SH, Mathiesen EB (2009) Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease. Curr Cardiol Rep 11:21–27CrossRefPubMed Johnsen SH, Mathiesen EB (2009) Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease. Curr Cardiol Rep 11:21–27CrossRefPubMed
12.
go back to reference Wendelhag I, Wiklund O, Wikstrand J (1993) Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessment of intima-media thickness and plaque occurrence. Arterioscler Thromb 13:1404–1411CrossRefPubMed Wendelhag I, Wiklund O, Wikstrand J (1993) Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessment of intima-media thickness and plaque occurrence. Arterioscler Thromb 13:1404–1411CrossRefPubMed
13.
go back to reference Bassett J, World Health Organization. Regional Office for the Western Pacific, IAftSoO, International Obesity Taskforce (2000) The Asia-pacific perspective: redefining obesity and its treatment. Health Communications Australia, Australia Bassett J, World Health Organization. Regional Office for the Western Pacific, IAftSoO, International Obesity Taskforce (2000) The Asia-pacific perspective: redefining obesity and its treatment. Health Communications Australia, Australia
14.
go back to reference Swerdloff RS, (2002) Proceedings of the endocrine society andropause consensus conferences 2000–2001. Continuing medical education series. The Endocrine Society, Chevy Chase Swerdloff RS, (2002) Proceedings of the endocrine society andropause consensus conferences 2000–2001. Continuing medical education series. The Endocrine Society, Chevy Chase
15.
go back to reference Tabara Y, Kohara K, Nakura J, Miki T (2001) Risk factor-gene interaction in carotid atherosclerosis: Effect of gene polymorphisms of renin-angiotensin system. J Hum Genet 46:278–284CrossRefPubMed Tabara Y, Kohara K, Nakura J, Miki T (2001) Risk factor-gene interaction in carotid atherosclerosis: Effect of gene polymorphisms of renin-angiotensin system. J Hum Genet 46:278–284CrossRefPubMed
16.
go back to reference Islam MS, Lehtimki T, Juonala M et al (2006) Polymorphism of the angiotensin-converting enzyme (ace) and angiotesinogen (agt) genes and their associations with blood pressure and carotid artery intima media thickness among healthy finnish young adults–the cardiovascular risk in young finns study. Atherosclerosis 188:316–322CrossRefPubMed Islam MS, Lehtimki T, Juonala M et al (2006) Polymorphism of the angiotensin-converting enzyme (ace) and angiotesinogen (agt) genes and their associations with blood pressure and carotid artery intima media thickness among healthy finnish young adults–the cardiovascular risk in young finns study. Atherosclerosis 188:316–322CrossRefPubMed
17.
go back to reference Hegele RA (1996) The pathogenesis of atherosclerosis. Clinica Chimica Acta 246:21–38CrossRef Hegele RA (1996) The pathogenesis of atherosclerosis. Clinica Chimica Acta 246:21–38CrossRef
18.
go back to reference Stoll G, Bendszus M (2006) Inflammation and atherosclerosis: Novel insights into plaque formation and destabilization. Stroke 37:1923–1932CrossRefPubMed Stoll G, Bendszus M (2006) Inflammation and atherosclerosis: Novel insights into plaque formation and destabilization. Stroke 37:1923–1932CrossRefPubMed
19.
go back to reference Hkkinen T, Karkola K, Yl-Herttuala S (2000) Macrophages, smooth muscle cells, endothelial cells, and t-cells express cd40 and cd40l in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and cd16 (fc gammariii). Virchows Archiv 437:396–405CrossRef Hkkinen T, Karkola K, Yl-Herttuala S (2000) Macrophages, smooth muscle cells, endothelial cells, and t-cells express cd40 and cd40l in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and cd16 (fc gammariii). Virchows Archiv 437:396–405CrossRef
20.
go back to reference Lee SH, Park JS, Kim W et al (2008) Impact of body mass index and waist-to-hip ratio on clinical outcomes in patients with st-segment elevation acute myocardial infarction (from the korean acute myocardial infarction registry). Am J Cardiol 102:957–965CrossRefPubMed Lee SH, Park JS, Kim W et al (2008) Impact of body mass index and waist-to-hip ratio on clinical outcomes in patients with st-segment elevation acute myocardial infarction (from the korean acute myocardial infarction registry). Am J Cardiol 102:957–965CrossRefPubMed
21.
go back to reference Wu FC, Tajar A, Pye SR et al (2008) Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: The european male aging study. J Clin Endocrinol Metab 93:2737–2745. doi:10.1210/jc.2007-1972 CrossRefPubMed Wu FC, Tajar A, Pye SR et al (2008) Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: The european male aging study. J Clin Endocrinol Metab 93:2737–2745. doi:10.​1210/​jc.​2007-1972 CrossRefPubMed
22.
go back to reference Yanase T, Fan W, Kyoya K et al (2008) Androgens and metabolic syndrome: Lessons from androgen receptor knock out (arko) mice. J Steroid Biochem Mol Biol 109:254–257CrossRefPubMed Yanase T, Fan W, Kyoya K et al (2008) Androgens and metabolic syndrome: Lessons from androgen receptor knock out (arko) mice. J Steroid Biochem Mol Biol 109:254–257CrossRefPubMed
23.
go back to reference Oh JY, Barrett-Connor E, Wedick NM, Wingard DL (2002) Endogenous sex hormones and the development of type 2 diabetes in older men and women: The rancho bernardo study. Diabetes Care 25:55–60CrossRefPubMed Oh JY, Barrett-Connor E, Wedick NM, Wingard DL (2002) Endogenous sex hormones and the development of type 2 diabetes in older men and women: The rancho bernardo study. Diabetes Care 25:55–60CrossRefPubMed
24.
go back to reference Kalyani RR, Dobs AS (2007) Androgen deficiency, diabetes, and the metabolic syndrome in men. Curr Opin Endocrinol Diabetes Obes 14:226–234CrossRefPubMed Kalyani RR, Dobs AS (2007) Androgen deficiency, diabetes, and the metabolic syndrome in men. Curr Opin Endocrinol Diabetes Obes 14:226–234CrossRefPubMed
25.
go back to reference Bates AS, Van’t Hoff W, Jones PJ, Clayton RN (1996) The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 81:1169–1172PubMed Bates AS, Van’t Hoff W, Jones PJ, Clayton RN (1996) The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 81:1169–1172PubMed
26.
go back to reference Kaye JM, Lightman SL (2006) Corticosteroids and the cardiovascular response to stress: A pilot study of the 35% co2 challenge in addison’s disease. Clin Endocrinol (Oxf) 65:282–286CrossRef Kaye JM, Lightman SL (2006) Corticosteroids and the cardiovascular response to stress: A pilot study of the 35% co2 challenge in addison’s disease. Clin Endocrinol (Oxf) 65:282–286CrossRef
27.
go back to reference Agha A, Liew A, Finucane F et al (2004) Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial acth deficiency. Clin Endocrinol (Oxf) 60:688–693CrossRef Agha A, Liew A, Finucane F et al (2004) Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial acth deficiency. Clin Endocrinol (Oxf) 60:688–693CrossRef
28.
go back to reference Danilowicz K, Bruno OD, Manavela M, Gomez RM, Barkan A (2008) Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study. Pituitary 11:279–285CrossRefPubMed Danilowicz K, Bruno OD, Manavela M, Gomez RM, Barkan A (2008) Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study. Pituitary 11:279–285CrossRefPubMed
29.
go back to reference Svartberg J, von Mhlen D, Mathiesen E, Joakimsen O, Bnaa KH, Stensland-Bugge E (2006) Low testosterone levels are associated with carotid atherosclerosis in men. J Intern Med 259:576–582CrossRefPubMed Svartberg J, von Mhlen D, Mathiesen E, Joakimsen O, Bnaa KH, Stensland-Bugge E (2006) Low testosterone levels are associated with carotid atherosclerosis in men. J Intern Med 259:576–582CrossRefPubMed
30.
go back to reference Blow B, Hagmar L, Eskilsson J, Erfurth EM (2000) Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. J Clin Endocrinol Metab 85:574–584 Blow B, Hagmar L, Eskilsson J, Erfurth EM (2000) Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. J Clin Endocrinol Metab 85:574–584
31.
go back to reference Vikan T, Johnsen SH, Schirmer H, Njlstad I, Svartberg J (2009) Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the tromsø study. Eur J Epidemiol 24:289–295CrossRefPubMed Vikan T, Johnsen SH, Schirmer H, Njlstad I, Svartberg J (2009) Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the tromsø study. Eur J Epidemiol 24:289–295CrossRefPubMed
32.
go back to reference Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, Jones TH (2004) The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab 89:3313–3318. doi:10.1210/jc.2003-031069 CrossRefPubMed Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, Jones TH (2004) The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab 89:3313–3318. doi:10.​1210/​jc.​2003-031069 CrossRefPubMed
Metadata
Title
Carotid atheromatic plaque is commonly associated with hypopituitary men
Authors
Joo Young Kim
Jae Won Hong
Sang Youl Rhee
Chul Sik Kim
Dae Jung Kim
Eun Jig Lee
Publication date
01-06-2011
Publisher
Springer US
Published in
Pituitary / Issue 2/2011
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-010-0265-0

Other articles of this Issue 2/2011

Pituitary 2/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine